1.24 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Talphera, Inc. Common Stock
TLPHNASDAQ • USD
1.24
↘ 0.00 (0.08%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
1.24
↘ 0.00 (0.08%)
Market: CLOSED
Talphera, Inc. Common Stock (TLPH) is currently trading at $1.24. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TLPH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 14, 2026.
Open?$1.26
High?$1.26
Low?$1.21
Prev. Close?$1.24
Volume?25.7K
Avg. Volume?250.6K
VWAP?$1.24
Rel. Volume?0.10x
Bid / Ask
Bid?$1.06 × 100
Ask?$1.44 × 100
Spread?$0.38
Midpoint?$1.25
Valuation & Ratios
Market Cap?64.4M
Shares Out?51.9M
Float?29.5M
Float %?56.8%
P/E Ratio?N/A
P/B Ratio?4.47
EPS?-$0.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Employees
12
Market Cap
64.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2011-02-11
Address
1850 GATEWAY DRIVE
SAN MATEO, CA 94404
Phone: 650-216-3500
SAN MATEO, CA 94404
Phone: 650-216-3500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?84
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.33Distress
Confidence?43%Low
Short InterestLow
Short % of Float?1.73%Low
Short Interest?508.6K
Days to Cover?2.2
Free Float29.5M
Avg Daily Volume233.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.79Adequate
Quick Ratio?1.79Adequate
Cash Ratio?0.07Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.47FAIR▾
Peers100
S&P40
P/S?64,363.19HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
S&P97
EV/Sales?63,621.19HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-104.7%WEAK▾
S&P3
ROA?-56.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12270000
Enterprise Value?$63.6M
Fundamentals ratios updated end of day